Product
Supplier
Encyclopedia
Inquiry
Home > News > Policy & Regulation
ECHEMI chemical news

Policy & Regulation

The Phenomenal Success of Semaglutide: A True Money Printing Machine!

The Phenomenal Success of Semaglutide: A True Money Printing Machine!

2024-02-01

In January 2023, Novo Nordisk released its financial report, revealing astounding global sales figures for their groundbreaking weight-loss drug, Semaglutide.

EU Revises Regulations on Alcoholic Beverage Categories and Additive Usage

EU Revises Regulations on Alcoholic Beverage Categories and Additive Usage

2024-01-30

The European Union (EU) has recently implemented new regulations pertaining to the categorization of alcoholic beverages and the usage of additives within certain alcoholic drinks.

Sino-Agri and Yangnong have reached a comprehensive strategic  cooperation

Sino-Agri and Yangnong have reached a comprehensive strategic cooperation

2024-01-29

On January 27, 2024, Sino-Agri and Yangnong held a strategic cooperation exchange meeting, jointly signed a strategic cooperation agreement, and formally became strategic partners.

China's Food Exports to South Korea Violate Regulations in January 2024 (Updated as of January 28th)

China's Food Exports to South Korea Violate Regulations in January 2024 (Updated as of January 28th)

2024-01-29

In January 2024, China's exports of food products to South Korea were found to be in violation of regulations.

Pay attention to REACH compliance! Five new hazardous chemicals added to ECHA SVHC candidate list

Pay attention to REACH compliance! Five new hazardous chemicals added to ECHA SVHC candidate list

2024-01-26

On January 23, 2024, the European Chemicals Agency (ECHA) added five new hazardous chemicals to the Substances of Very High Concern (SVHC) candidate list, and the list was officially updated to 240 items.

ALPHAMAB, 3D Medicines, and Glenmark Reach $700 Million Licensing Agreement for KN035

ALPHAMAB, 3D Medicines, and Glenmark Reach $700 Million Licensing Agreement for KN035

2024-01-25

In a significant development, ALPHAMAB Biopharmaceuticals, in collaboration with 3D Medicines, has announced a groundbreaking licensing agreement worth over $700 million for their PD-L1 antibody drug, KN035.

Youdao Chemical's Chlorantraniliprole technical plant has reached production with a total capacity of 11,000 tons

Youdao Chemical's Chlorantraniliprole technical plant has reached production with a total capacity of 11,000 tons

2024-01-22

Since the trial production in December 2023, after more than one month of commissioning and operation, the current indicators of Youdao Chemical's Chlorantraniliprole technical plant fully meet the design requirements and successfully reach production!

Unveiling the Chemical Transformation: White Phosphorus Reacts with Thionyl Chloride to Give Remarkable Products

Unveiling the Chemical Transformation: White Phosphorus Reacts with Thionyl Chloride to Give Remarkable Products

2024-01-19

This original article explores the intriguing reaction between white phosphorus and thionyl chloride, emphasizing its transformative nature and investigating its diverse applications in various industries.

Is the FDA Failing to Address the Serious Side Effects of a Widely Prescribed Asthma Medication?

Is the FDA Failing to Address the Serious Side Effects of a Widely Prescribed Asthma Medication?

2024-01-12

In recent years, concerns have escalated regarding the potential side effects of a commonly prescribed asthma and allergy medication.

FDA Proposes Ban on Brominated Vegetable Oil Due to Health Risks

FDA Proposes Ban on Brominated Vegetable Oil Due to Health Risks

2024-01-11

The Food and Drug Administration (FDA) has recently proposed a ban on the use of brominated vegetable oil (BVO), a food ingredient commonly found in certain beverages like Gatorade and Mountain Dew.

FDA Proposes Ban on Brominated Vegetable Oil Due to Health Risks

FDA Proposes Ban on Brominated Vegetable Oil Due to Health Risks

2024-01-11

The Food and Drug Administration (FDA) has recently proposed a ban on the use of brominated vegetable oil (BVO), a food ingredient commonly found in certain beverages like Gatorade and Mountain Dew.

AiolosBio: The Middleman with an Eye for Opportunity in the Pharmaceutical Industry?

AiolosBio: The Middleman with an Eye for Opportunity in the Pharmaceutical Industry?

2024-01-10

On January 9, pharmaceutical giant GlaxoSmithKline (GSK) announced its acquisition agreement with AiolosBio, a move aimed at strengthening its portfolio in the respiratory and inflammation drug market.

Can Lecanemab Revolutionize Alzheimer's Disease Treatment?

Can Lecanemab Revolutionize Alzheimer's Disease Treatment?

2024-01-10

Alzheimer's disease (AD) poses a significant challenge worldwide, affecting millions of individuals and their families. However, a breakthrough may be on the horizon with the recent approval of Lecanemab-irmb, a novel drug developed by Eisai

Study Finds Semaglutide Lower Suicide Ideation Risk Compared to Other Diabetes and Obesity Medications

Study Finds Semaglutide Lower Suicide Ideation Risk Compared to Other Diabetes and Obesity Medications

2024-01-10

According to a new federally-funded study by the National Institutes of Health, the drugs semaglutide, commonly used to treat diabetes and obesity, have been found to reduce the risk of suicide ideation in patients compared to other medications used for t

Can Florida's Authorization to Import Prescription Drugs from Canada Lower Medication Prices?

Can Florida's Authorization to Import Prescription Drugs from Canada Lower Medication Prices?

2024-01-08

In a groundbreaking move, the U.S. Food and Drug Administration (FDA) has granted Florida permission to directly import prescription drugs from Canada.

Is FDA Doing Enough to Ensure the Safety of Food Additives?

Is FDA Doing Enough to Ensure the Safety of Food Additives?

2024-01-08

In a closely-watched development, California legislators recently passed a bill that could ban the sale of certain food additives in the state.

Announcement: ECHEMI Data Upgrade Notice

Announcement: ECHEMI Data Upgrade Notice

2024-01-04

The ECHEMI data server will be upgraded. After the upgrade, the stability and data timeliness in 2024 can be significantly improved.

Are GLP-1 Receptor Agonists Linked to Hair Loss and Suicidal Thoughts?

Are GLP-1 Receptor Agonists Linked to Hair Loss and Suicidal Thoughts?

2024-01-04

The US Food and Drug Administration (FDA) is closely examining reports of potential side effects associated with certain medications like Ozempic, Mounjaro, and Wegovy.

Medytox Establishes U.S. Subsidiary to Expand BTX Market’s Global Reach

Medytox Establishes U.S. Subsidiary to Expand BTX Market’s Global Reach

2024-01-03

Meditox, a Korean botulinum toxin (BTX) manufacturer, said it has established a U.S. subsidiary, Luvantas, to enter the global market with its non-animal-derived liquid BTX preparation MT10109L.

Is Promethazine Hydrochloride Injection Putting Patients at Risk? FDA Alerts Healthcare Professionals

Is Promethazine Hydrochloride Injection Putting Patients at Risk? FDA Alerts Healthcare Professionals

2023-12-28

Is Promethazine Hydrochloride Injection Putting Patients at Risk? FDA Alerts Healthcare Professionals.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.